Vitamin D intervention for Colorectal Carcinoma

Phase-Based Progress Estimates
Baylor University, Waco, TX
Colorectal Carcinoma+1 More
Vitamin D intervention - DietarySupplement
All Sexes
What conditions do you have?

Study Summary

This trial will study the effect of vitamin D supplementation on the microbiome in healthy humans. Vitamin D intervention is used to treat Colorectal Carcinoma. This is not the first time that it has been approved by the FDA for a different condition.

Eligible Conditions

  • Colorectal Carcinoma

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Colorectal Carcinoma

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 12 weeks

12 weeks
Microbiome alterations

Trial Safety

Safety Progress

1 of 3

Other trials for Colorectal Carcinoma

Trial Design

2 Treatment Groups

Vitamin D intervention
1 of 2
Placebo intervention
1 of 2
Experimental Treatment
Non-Treatment Group

43 Total Participants · 2 Treatment Groups

Primary Treatment: Vitamin D intervention · Has Placebo Group · N/A

Vitamin D intervention
Experimental Group · 1 Intervention: Vitamin D intervention · Intervention Types: DietarySupplement
Placebo intervention
PlaceboComparator Group · 1 Intervention: Placebo intervention · Intervention Types: DietarySupplement

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 12 weeks
Closest Location: Baylor University · Waco, TX
Photo of texas 1Photo of texas 2Photo of texas 3
2011First Recorded Clinical Trial
0 TrialsResearching Colorectal Carcinoma
23 CompletedClinical Trials

Who is running the clinical trial?

Baylor UniversityLead Sponsor
43 Previous Clinical Trials
63,608 Total Patients Enrolled
Kristen L Greathouse, PhDPrincipal InvestigatorBaylor University

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.